跳至主要内容
临床试验/JPRN-UMIN000001000
JPRN-UMIN000001000已完成未知

Efficacy of entecavir for chronic hepatitis B patients after curative treatment of hepatocellular carcinoma :randomized controlled trial - ETV for CH-B after HCC treatment

niversity of Tokyo Department of Gastroenterology, Faculty of Medicine0 个研究点目标入组 44 人开始时间: 2008年1月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The exclusion criteria are as follows: a previous history of a severe drug hypersensitivity against an ingredients of Entecavir, extrahepatic metastasis lesion of HCC, malignancy except for HCC (double cancer), severe renal disease (BUN more than 40 mg/dl or creatinine more than 2.0 mg/dl), the presence of other forms of liver disease such as auto immune hepatitis, coinfection with hepatitis C, history of liver transplantation, participation in another clinical trial, and doctors' stop not to register to the study.

研究者

发起方
niversity of Tokyo Department of Gastroenterology, Faculty of Medicine

相似试验